Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KOSDAQ/058820 stock hub

KOSDAQ/058820 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/058820is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

234.5B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/058820

In the news

Latest news · KOSDAQ/058820

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-5.2

P25 -17.1P50 0.7P75 8.5

ROIC-1.5

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/058820 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

KRW

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	223
Enterprise value	KRW 280B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7058820002
Last refreshed	2026-05-10
Market cap	KRW 234.5B
Price	KRW 1,586
Price currency	KRW
Rev Per Employee	471,879,751.93x
Sector	Healthcare
Sic	2834
Symbol	kosdaq/058820
Website	https://www.cmgpharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.3%
EV Earnings	-27.78x
EV/FCF	-6.89x
EV/Sales	2.66x
FCF yield	-17.34%
P/B ratio	1.16x
P/S ratio	2.23x
PE Ratio10 Y	207.92x
PE Ratio3 Y	75.23x
PE Ratio5 Y	99.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.51%
EBITDA Margin	-0.58%
Gross margin	57.85%
Gross Profit	KRW 60.9B
Gross Profit Growth	33.38%
Gross Profit Growth Q	32.76%
Gross Profit Growth3 Y	14.32%
Gross Profit Growth5 Y	24.17%
Net Income	KRW -10.1B
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-11.25%
Profit Margin	-9.58%
Profit Per Employee	KRW -45.2M
ROA	-0.76
ROCE	-1.83
ROE	-5.15
ROIC	-1.53
Roic5y	1.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.86%
Cagr15y	8.1%
Cagr1y	-32.24%
Cagr20y	-9.84%
Cagr3y	-10.06%
Cagr5y	-18.74%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	6.19x
Revenue Growth Q	18.02x
Revenue Growth Quarters	2x
Revenue Growth Years	9x
Revenue Growth3 Y	8.58x
Revenue Growth5 Y	18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.35
Assets	KRW 306B
Cash	KRW 26.5B
Current Assets	KRW 95.2B
Current Liabilities	KRW 103.7B
Debt	KRW 72B
Debt Equity	KRW 0.36
Debt FCF	KRW -1.77
Equity	KRW 201.6B
Interest Coverage	-1.17
Liabilities	KRW 104.4B
Long Term Assets	KRW 210.8B
Long Term Liabilities	KRW 750.8M
Net Cash	KRW -45.5B
Net Cash By Market Cap	KRW -19.41
Net Debt Equity	KRW 0.23
Tangible Book Value	KRW 195.8B
Tangible Book Value Per Share	KRW 1,334
WACC	6.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.92
Inventory Turnover	1.66
Net Working Capital	KRW 36.9B
Quick ratio	0.6
Working Capital	KRW -8.5B
Working Capital Turnover	KRW 4.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	73.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-64.58%
1Y total return	-32.22%
200-day SMA	1,875.2
3Y total return	-27.25%
50-day SMA	1,784.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.56%
All Time High	19,650.2
All Time High Change	-91.93%
All Time High Date	2006-05-04
All Time Low	429
All Time Low Change	269.7%
All Time Low Date	2011-04-28
ATR	58.5
Beta	0.59
Beta1y	0.38
Beta2y	0.43
Ch YTD	-14.64
High	1,640
High52	2,420
High52 Date	2025-05-13
High52ch	-35.53%
Low	1,549
Low52	1,549
Low52 Date	2026-05-08
Low52ch	2.19%
Ma50ch	-11.12%
Price vs 200-day SMA	-15.42%
RSI	30.32
RSI Monthly	38.41
RSI Weekly	38.28
Sharpe ratio	-1.34x
Sortino ratio	-1.76
Total Return	73.29%
Tr YTD	-14.64
Tr15y	221.85%
Tr1m	-8.43%
Tr1w	-7.58%
Tr3m	-22.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -3.7B
Operating Income Growth Q	125.4
Operating margin	-3.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109,966,411%
Net Borrowing	1,253,127,730
Shares Institutions	3.81%
Shares Out	147,842,183
Shares Qo Q	-0.48%
Shares Yo Y	-73.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -40.7B
Average Volume	680,508.55x
Bv Per Share	1,373
CAPEX	KRW -29.6B
Ch10y	-69.32
Ch15y	178.7
Ch1m	-8.43
Ch1w	-7.58
Ch1y	-32.22
Ch20y	-89.1
Ch3m	-22.63
Ch3y	-27.25
Ch5y	-64.56
Ch6m	-7.14
Change	-2.88%
Change From Open	-3.29
Close	1,633
Days Gap	0.43
Depreciation Amortization	3,082,049,820
Dollar Volume	2,770,366,118
Earnings Date	2026-04-03
EBIT	KRW -3.7B
EBITDA	KRW -610.4M
EPS	KRW -70
F Score	1
FCF	KRW -40.7B
FCF EV Yield	-14.52x
FCF Per Share	KRW -275
Financing CF	945,791,040
Fiscal Year End	December
Founded	2,001
Goodwill	2,273,770,370
Income Tax	KRW -1.8B
Investing CF	13,626,304,710
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2007-08-28
Last Split Type	Forward
Ma150	1,853.5
Ma150ch	-14.43%
Ma20	1,772
Ma20ch	-10.49%
Net CF	3,534,721,450
Open	1,640
Position In Range	40.66
Ppne	114,993,939,820
Price Date	2026-05-08
Ptbv Ratio	1.2
Relative Volume	2.85x
Revenue	105,229,184,680x
SBC By Revenue	0.04x
Share Based Comp	40,218,020
Tax By Revenue	-1.67x
Tr20y	-87.41%
Tr6m	-7.14%
Volume	1,746,763
Z Score	1.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/058820 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/058820 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/058820?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-73.3%

Negative means the company is buying back shares.

Technical

KOSDAQ/058820 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.3

Neutral momentum band

Price vs 200-day MA

-15.4%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

-1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/058820

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/058820 stock rating?

kosdaq/058820 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/058820 analysis?

The full report lives at /stocks/kosdaq/058820/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/058820?

The latest report frames kosdaq/058820 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/058820 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.